In a health consumer market often saturated with topical solutions, a significant disconnect remains between "external maintenance" and "internal regulation." While the majority of the beauty sector focuses on epidermal modification, the biological reality is that visible signs of decline—skin laxity, dullness, and loss of vitality—are merely symptoms of systemic dysfunction originating at the cellular level.
Addressing this gap, the French cellular-tech brand FÉLICIA BEAUTÉ has released a new theoretical framework for "Cellular-Level Endogenous Anti-Ageing." Moving beyond traditional supplementation, the brand proposes a systemic intervention model that targets the microscopic drivers of human health.
The "Gold Standard" of Senescence: A Data-Driven Compass
The brand’s R&D strategy is grounded in the "Gold Standard" of ageing identification, as published by research teams from Sorbonne University in the prestigious journal Cell. Based on this academic foundation, FÉLICIA BEAUTÉ has constructed an "Anti-Ageing Matrix Compass" that targets 14 distinct biological markers of decline.
To ensure scientific rigour, every marker included in this research system must satisfy three strict criteria:
Correlation: It must show a significant correlation with increasing chronological age.
Acceleration: Artificially enhancing the marker must accelerate the ageing process.
Predictability: Artificially suppressing the marker must demonstrably delay ageing.
The Tri-Layer Mechanism: Cell-Organ-Body
Breaking the limitations of single-nutrient supplementation, FÉLICIA BEAUTÉ has introduced a closed-loop scientific protocol that operates across three dimensions: Cell Metabolism, Organ Function, and Body Homeostasis.
At the cellular tier, the brand utilises high-activity proprietary compounds—including L-Ergothioneine, Black Truffle Extract, and the patented Gerolytix™ complex—to optimise mitochondrial energy synthesis. This induces autophagy in senescent cells , a critical mechanism for clearing metabolic debris and restoring cellular efficiency.
Clinical Data: The Quantifiable Impact
The efficacy of this formulation is supported by specific clinical metrics regarding its key active ingredients:
Mitochondrial & NAD+ Optimisation:
PQQ (Pyrroloquinoline Quinone): Treated cells showed an approximate 169% increase in functional mitochondrial proportion.
Pomegranate Extract: Continuous administration resulted in a 100% increase in cellular NAD+ levels.
AKG (Alpha-Ketoglutarate): Demonstrated an approximate 66.7% elevation in NAD levels.
Systemic & Epigenetic Rejuvenation:
Dermatological Impact: Studies indicate a 17.10% reduction in wrinkles, a 30% increase in collagen synthesis, and a staggering 320% surge in fibroblast collagen production. Skin firmness improved by 116.7%.
Reproductive Health: Metrics showed a 58% increase in follicle count and a 57% rise in AMH (Anti-Müllerian Hormone) levels.
Epigenetic Age Reversal: In longitudinal studies involving AKG supplementation over 7 months, results showed a reduction in epigenetic age by 8.44 years in males and 6.98 years in females.
Industrial Backing
This scientific leap is powered by Laboratoire CEVRAI, a leading French manufacturing facility for nutritional supplements. By integrating 30 years of clinical data with real-world human sample tracking, FÉLICIA BEAUTÉ is attempting to standardise a new paradigm: moving from vague "wellness" concepts to quantifiable, cellular-level health engineering.